ID   EL-4 6.1
AC   CVCL_A0DM
SY   EL4-6.1; EL4-16 BuOu6.1
DR   Wikidata; Q108820188
RX   PubMed=2415592;
CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC   Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
RX   PubMed=2415592; DOI=10.4049/jimmunol.135.6.3944;
RA   MacDonald H.R., Lees R.K., Bron C.;
RT   "Cell surface glycoproteins involved in the stimulation of interleukin
RT   1-dependent interleukin 2 production by a subline of EL4 thymoma
RT   cells. I. Functional characterization by monoclonal antibodies.";
RL   J. Immunol. 135:3944-3950(1985).
//